Translating Research Into Practice
Review of a Study of Duloxetine for Painful Chemotherapy-Induced Peripheral Neuropathy
Rita Wickham, PhD, RN, AOCN®
Independent Oncology and Palliative Care Consultant
The author has no conflicts of interest to disclose.
Correspondence to: Rita Wickham, PhD, RN, AOCN®. E-mail: firstname.lastname@example.org
J Adv Pract Oncol 2013;4:361–368 |
DOI: 10.6004/jadpro.2013.4.5.8 |
© 2013 Harborside Press®
In a recent issue of JAMA, Smith et al. evaluated the use of duloxetine in the treatment of patients with painful chemotherapy-induced peripheral neuropathy (CIPN). Here, JADPRO contributors give an overview of the Smith study and offer a researcher’s perspective on the challenges associated with studying CIPN.
For access to the full length article, please sign in